1-3 of 3
Monica Boen, BA
Close
Sort by
Journal Articles

Erythropoietin Stimulating Agents (ESAs): Reassessment of Use in Cancer and Chronic Kidney Disease (CKD) Settings in the United States, Canada, and Europe.

Charles L Bennett, MD, PhD, Athena T Samaras, BA, June M McKoy, MD, JD, MPH, Beatrice J Edwards, MD, FACP, Mi Zheng, Matthew J Fisher, BA, Simone N Boyle, BA, Steven M Trifilio, RPh, Monica Boen, BA, Dianne Deleon, BA, Dennis P West, PhD
Journal: Blood
Blood (2009) 114 (22): 4538.
https://doi.org/10.1182/blood.V114.22.4538.4538
Published: 2009
Journal Articles

Connecticut Attorney General Blumenthal's Citizen Petition Regarding Thalidomide-Associated VTE Redux: Patient Safety Concerns Still Persist.

June M. McKoy, MD, JD, MPH, Monica Boen, BA, Dianne Deleon, BA, Josephine Feliciano, MD, D. Mark Courtney, MD, Charles L. Bennett, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3990.
https://doi.org/10.1182/blood.V114.22.3990.3990
Published: 2009
Journal Articles

Thalidomide (thal), Lenalidomide (len), and Dexamethasone (dex)-Associated Venous Thromboembolism (VTE) and Reported VTE Rates Pre- and Post-FDA Approval: Optimal Prophylaxis Strategies Are Still Unclear

Monica Boen, BA, June McKoy, MD, MPH, Dennis West, Beatrice Edwards, Jayesh Mehta, Seema Singhal, Charles L. Bennett, MD, PhD, MPP
Journal: Blood
Blood (2008) 112 (11): 2403.
https://doi.org/10.1182/blood.V112.11.2403.2403
Published: 2008